Sumitomo Corporation competitors

C-Level Executive with demonstrated leadership skills and proven business results in Pharmaceuticals (Branded and Generics), Sales, Marketing, Operations, Business Development, R&D/Regulatory.I'm a creative problem-solver, with a track record of outstanding results through professional and interpersonal skills including strategic vision, team development, people management, prioritization, motivation, decisiveness and grit.

Chris Simon is a President and Chief Executive Officer at Haemonetics and Board Member at Haemonetics and is based in Braintree, Massachusetts. He has worked as Senior Partner at McKinsey & Company, Hospital Supply and Scientific Products at Baxter Healthcare Corporation, and Infantry Officer at United States Army. Christopher attended The Wharton School between 1981 and 1985 and Harvard Business School between 1991 and 1993.

John F. Sheridan has served as our President and Chief Executive Officer since March 2019 and as a member of our Board of Directors since June 2019. Prior to joining our company, Mr. Sheridan served as Chief Operating Officer of Rapiscan Systems, Inc., a provider of security equipment and systems, from March 2012 to February 2013. Mr. Sheridan served as Executive Vice President of Research and Development and Operations for Volcano Corporation (NASDAQ: VOLC), a medical technology company, from November 2004 to March 2010. From May 2002 to May 2004, Mr. Sheridan served as Executive Vice President of Operations at CardioNet, Inc., a medical technology company. From March 1998 to May 2002, he served as Vice President of Operations at Digirad Corporation, a medical imaging company. Mr. Sheridan holds a B.S. in Chemistry from the University of West Florida and an M.B.A. from Boston University.

Chad Holzer is a President, Image Transfer Technologies at Flint Group and Chief Executive Officer at Accupac and is based in Philadelphia, Pennsylvania. He has worked as Global Business Director - Specialty Monomers at Dow, Global Vice President and General Manager at Flint Group, and North American Business Director; Acrylics & Plexiglas Materials at Dow. Chad attended Harvard Business School between 2007 and 2009 and Cornell University between 1998 and 2002.

George Hanford is a Chief Executive Officer at Hanford Pharmaceuticals and is based in Syracuse, New York.